274 related articles for article (PubMed ID: 12923429)
21. Murine anti-mouse T cell monoclonal antibodies elicit anti-antibodies in mice: intra-species immunization model for estimating potential patient sensitization against humanized anti-T cell antibodies.
Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
Eur J Immunol; 1993 May; 23(5):1017-22. PubMed ID: 8097469
[TBL] [Abstract][Full Text] [Related]
22. Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
Kimura S; Watanabe A; Takeuchi M; Nagata M; Harada M
Immunol Invest; 1998 Dec; 27(6):379-93. PubMed ID: 9845423
[TBL] [Abstract][Full Text] [Related]
23. Anti-anti-IgE idiotypic antibodies mimic IgE in their binding to the Fc epsilon receptor.
Baniyash M; Eshhar Z
Eur J Immunol; 1987 Sep; 17(9):1337-42. PubMed ID: 2443366
[TBL] [Abstract][Full Text] [Related]
24. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies.
Shimada E; Tadokoro K; Watanabe Y; Ikeda K; Niihara H; Maeda I; Isa K; Moriya S; Ashida T; Mitsunaga S; Nakajima K; Juji T
Transfusion; 2002 Jun; 42(6):766-73. PubMed ID: 12147031
[TBL] [Abstract][Full Text] [Related]
25. [Interleukin-2 receptor blockers in renal transplantation].
Basić-Jukić N; Bubić-Filipi L; Danić A; Pasini J; Kes P
Acta Med Croatica; 2004; 58(5):395-9. PubMed ID: 15756806
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
27. High susceptibility of cataract Shionogi (CTS) mice to passive anaphylactic shock mediated by allogeneic IgE and IgG1 monoclonal antibodies.
Harada M; Nagata M; Takeuchi M; Makino S; Aburahi S
Immunol Invest; 1991 Jun; 20(3):305-15. PubMed ID: 1874560
[TBL] [Abstract][Full Text] [Related]
28. Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes.
Lustgarten J; Eshhar Z
Eur J Immunol; 1995 Oct; 25(10):2985-91. PubMed ID: 7589102
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactive idiotypes on high affinity IgG class human monoclonal thyroglobulin autoantibodies.
Delves PJ; McLachlan SM; Drewe E; Fukuma N; Petersen VB; Smith BR
J Autoimmun; 1993 Feb; 6(1):77-91. PubMed ID: 8457287
[TBL] [Abstract][Full Text] [Related]
30. Effect of anti-IgE antibodies on Fc epsilonRI-bound IgE.
Rudolf MP; Furukawa K; Miescher S; Vogel M; Kricek F; Stadler BM
J Immunol; 1996 Dec; 157(12):5646-52. PubMed ID: 8955217
[TBL] [Abstract][Full Text] [Related]
31. IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies.
Baan CC; Boelaars-van Haperen MJ; van Riemsdijk IC; van der Plas AJ; Weimar W
Transplant Proc; 2001 May; 33(3):2244-6. PubMed ID: 11377516
[No Abstract] [Full Text] [Related]
32. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients.
Grego K; Arnol M; Bren AF; Kmetec A; Tomaziĉ J; Kandus A
Transplant Proc; 2007 Dec; 39(10):3093-7. PubMed ID: 18089329
[TBL] [Abstract][Full Text] [Related]
33. A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations.
Kovarik JM; Offner G; Broyer M; Niaudet P; Loirat C; Mentser M; Lemire J; Crocker JF; Cochat P; Clark G; Gerbeau C; Chodoff L; Korn A; Hall M
Transplantation; 2002 Oct; 74(7):966-71. PubMed ID: 12394838
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens.
de Leon MP; Drew AC; Glaspole IN; Suphioglu C; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2005 Aug; 35(8):1056-64. PubMed ID: 16120088
[TBL] [Abstract][Full Text] [Related]
35. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
[TBL] [Abstract][Full Text] [Related]
36. Anti-CD25 monoclonal antibody sequential immunosuppressive induction therapy in renal transplants with high risk of delayed graft function.
González E; Gutiérrez E; Hernández Y; Roselló G; Gutiérrez MJ; Martínez EG; Manzanera MJ; García JA; Praga M; Morales JM; Andrés A
Transplant Proc; 2005 Nov; 37(9):3736-7. PubMed ID: 16386522
[TBL] [Abstract][Full Text] [Related]
37. Basiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver transplantation: comparative study.
Gibelli NE; Pinho-Apezzato ML; Miyatani HT; Maksoud-Filho JG; Silva MM; Ayoub AA; Santos MM; Velhote MC; Tannuri U; Maksoud JG
Transplant Proc; 2004 May; 36(4):956-7. PubMed ID: 15194332
[TBL] [Abstract][Full Text] [Related]
38. Clinical advances in therapies targeting the interleukin-2 receptor.
Church AC
QJM; 2003 Feb; 96(2):91-102. PubMed ID: 12589007
[No Abstract] [Full Text] [Related]
39. Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor "holiday" in solid organ transplant patients with acute renal dysfunction.
Cantarovich M; Metrakos P; Giannetti N; Cecere R; Barkun J; Tchervenkov J
Transplantation; 2002 Apr; 73(7):1169-72. PubMed ID: 11965054
[TBL] [Abstract][Full Text] [Related]
40. Anaphylactic shock after retreatment with basiliximab.
Barros VR; Rocha V; Garcia VD; Garcia CD
Transplant Proc; 2003 Feb; 35(1):579. PubMed ID: 12591539
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
